Results from the first English stool bank using faecal microbiota transplant as a medicinal product for the treatment of Clostridioides difficile infection
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Authors
McCune, VLQuraishi, MN
Manzoor, S
Moran, CE
Banavathi, K
Steed, H
Massey, DCO
Trafford, GR
Iqbal, TH
Hawkey, PM
Issue Date
2020-03-16
Metadata
Show full item recordAbstract
© 2020 Background: Faecal Microbiota Transplant (FMT) has improved outcomes for the treatment of Clostridioides difficile infection (CDI) compared to antibiotic therapy. FMT is classified as a medicinal product in the United Kingdom, similar to the USA and Canada, limiting supply via stool banks without appropriate licencing. In the largest UK cohort to date, we describe the clinical outcomes for 124 patients receiving FMT for recurrent or refractory CDI and present a framework to produce FMT as a licenced medicinal product. Methods: Anonymous unrelated healthy donors, screened via health assessment and microbiological testing donated stool. In aerobic conditions FMT aliquots were prepared for immediate use or frozen storage, following a production framework developed to comply with Good Manufacturing Practice. Outcome measures were clinical response to FMT defined as resolution of diarrhoea within seven days and clinical cure defined as response without diarrhoea recurrence at 90 days. Findings: Clinical response was 83·9% (95% CI 76·0%–90·0%) after one treatment. Clinical cure was 78·2% (95% CI 67·4%–89·0%) across the cohort. Refractory cases appeared to have a lower initial clinical response rate compared to recurrent cases, however at day 90 there were no differences observed between these groups. Interpretation: The methodology developed here enabled successful licencing of FMT by The Medicines and Healthcare products Regulatory Agency as a medicinal product. This has widened the availability of FMT in the National Health Service via a stool bank and can be applied in other centres across the world to improve access to safe and quality assured treatments.Citation
McCune, V. L., Quraishi, M. N., Manzoor, S., Moran, C. E. et al. (2020) Results from the first English stool bank using faecal microbiota transplant as a medicinal product for the treatment of Clostridioides difficile infection, EClinicalMedicine, 20, 100301. doi: 10.1016/j.eclinm.2020.100301Publisher
Elsevier BVJournal
EClinicalMedicinePubMed ID
32300746 (pubmed)Type
Journal articleLanguage
enDescription
© 2020 The Authors. Published by Elsevier. This is an open access article available under a Creative Commons licence. The published version can be accessed at the following link on the publisher’s website: https://doi.org/10.1016/j.eclinm.2020.100301ISSN
2589-5370EISSN
2589-5370Sponsors
No funding was received for this study.ae974a485f413a2113503eed53cd6c53
10.1016/j.eclinm.2020.100301
Scopus Count
Collections
Except where otherwise noted, this item's license is described as Licence for published version: Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International
Related articles
- Results from the first English stool bank using faecal microbiota transplant as a medicinal product for the treatment of Clostridioides difficile infection.
- Authors: McCune VL, Quraishi MN, Manzoor S, Moran CE, Banavathi K, Steed H, Massey DCO, Trafford GR, Iqbal TH, Hawkey PM
- Issue date: 2020 Mar
- Faecal microbiota transplantation for recurrent Clostridioides difficile infection: experience with lyophilized oral capsules.
- Authors: Reigadas E, Bouza E, Olmedo M, Vázquez-Cuesta S, Villar-Gómara L, Alcalá L, Marín M, Rodríguez-Fernández S, Valerio M, Muñoz P
- Issue date: 2020 Jun
- [Faecal microbiota transplantation for Clostridioides difficile infection].
- Authors: Waldbaum C, López F, Antelo P, Sorda J
- Issue date: 2020
- [Reconsidering the technical aspects and quality management background of faecal microbiota transplantation due to the novel coronavirus pandemic].
- Authors: Nagy GG, Tudlik Z, Gergely L, Kónya J, Orosi P, Rákóczi É, Szabó J, Várvölgyi C, Vitális E, Paragh G
- Issue date: 2020 Nov 1